.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Max Healthcare Institute Ltd has officially joined an international research consortium under the Indo-EU COMBAT initiative. This dengue research initiative aims to strengthen global preparedness for mosquito-borne diseases. Supported by the Department of Biotechnology and the European Commission, the project brings together elite institutions from India and Europe. Consequently, they aim to develop technology-driven approaches for understanding, diagnosing, and managing dengue.
The consortium secured a major research grant to study disease progression. Specifically, researchers will focus on identifying early warning markers to improve patient outcomes. Representing Max Healthcare are principal investigators Sandeep Budhiraja and Atul Thatai. Furthermore, Ujjwal Neogi from the Karolinska Institute facilitated this collaboration. The BRIC National Institute of Biomedical Genomics leads the Indian effort. Because dengue remains a significant health concern, this project integrates multi-omics technologies and artificial intelligence. This combination helps researchers identify predictive biomarkers for earlier diagnosis.
Dengue continues to pose a major public health challenge in tropical regions. Therefore, partnerships that combine clinical expertise with advanced research are essential. Dr. Budhiraja noted that these collaborations strengthen early diagnosis and improve patient response strategies. Similarly, Dr. Neogi highlighted the importance of data-driven solutions. Moreover, these innovations help build stronger surveillance and treatment frameworks. As a result, the initiative advances global pandemic preparedness through cross-border scientific cooperation.
Q1: What is the primary goal of the Indo-EU COMBAT initiative?
The primary goal is to strengthen dengue research and improve global preparedness for mosquito-borne diseases through collaborative research and technology-driven approaches.
Q2: How will multi-omics and AI be used in this research?
The program will combine multi-omics technologies, clinical data, and artificial intelligence to better understand how dengue progresses and identify predictive biomarkers for earlier clinical interventions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Max Healthcare joins Indo-EU COMBAT initiative to advance dengue research using multi-omics and AI for early diagnosis and better patient outcomes....
5 months ago
A breakthrough study evaluated H5N1 transmission efficiency across mammalian isolates. Researchers discovered that human-derived D1.1 harboring the PB2 D701N mutation spread efficiently in ferrets, unlike strains carrying PB2 E627K. This finding highlights critical genetic markers for zoonotic surveillance.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
